According to The Insight Partners, The Insulin Lispro market was valued at US$ 8.42 billion in 2025 and is expected to reach US$ 13.55 billion by 2034; it is estimated to record a CAGR of 5.43% during 2026-2034. The market growth is primarily associated with the increasing global burden of diabetes and the need for effective, fast-acting insulin therapies. Insulin lispro is a rapid-acting...